Medical cannabis company sells its first marijuana pills

Research has shown that ingredients can help with chronic pain, cancer, anxiety, diabetes, epilepsy, rheumatoid arthritis, PTSD, sleep disorders and more, company claims

Andrew Griffin
Monday 31 August 2015 13:03
Comments
A man cuts flowers of a cannabis plant at his house back yard in Montevideo on April 25, 2014
A man cuts flowers of a cannabis plant at his house back yard in Montevideo on April 25, 2014

A company has sold its first marijuana pills legally, and they are available to buy over the internet in Europe.

The company sells CBD, or cannabidoil, capsules. They are made from a strain of marijuana that helps keep the CBD but not contain tetrahydrocannabinol, or THC, which causes the intoxicating and psychological effects of marijuana.

The company says that CBD can help with chronic pain, cancer, anxiety, diabetes, epilepsy, rheumatoid arthritis, PTSD, sleep disorders, cardiovascular disease, antibiotic-resistant infections, and various neurological ailments.

The company, MMJ PhytoTech, is based in Australia, where medical marijuana is still mostly illegal. But the capsules are made in Switzerland and registered in Germany, and can be bought in Europe through the company’s online store.

A 10 milligram box of the pills can be bought for €89 on the company’s direct sales website. The company said that it had seen “strong interest from retail customers” on the site.

It hopes to sell 1 million capsules in 2015.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Please enter a valid email
Please enter a valid email
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Please enter your first name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
Please enter your last name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
You must be over 18 years old to register
You must be over 18 years old to register
Opt-out-policy
You can opt-out at any time by signing in to your account to manage your preferences. Each email has a link to unsubscribe.

By clicking ‘Create my account’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Join our new commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in